4.89
전일 마감가:
$4.90
열려 있는:
$4.96
하루 거래량:
565.31K
Relative Volume:
0.58
시가총액:
$158.28M
수익:
$105.38M
순이익/손실:
$17.78M
주가수익비율:
1.8315
EPS:
2.67
순현금흐름:
$-50.48M
1주 성능:
-5.78%
1개월 성능:
+59.28%
6개월 성능:
+81.78%
1년 성능:
+54.26%
Mei Pharma Inc Stock (MEIP) Company Profile
명칭
Mei Pharma Inc
전화
858-369-7100
주소
11455 EL CAMINO REAL, SAN DIEGO, CA
MEIP을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
MEIP
Mei Pharma Inc
|
4.89 | 158.60M | 105.38M | 17.78M | -50.48M | 2.67 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-07-23 | 다운그레이드 | Laidlaw | Buy → Hold |
2022-03-25 | 다운그레이드 | Jefferies | Buy → Hold |
2022-03-25 | 다운그레이드 | Stifel | Buy → Hold |
2022-03-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2022-02-03 | 개시 | Jefferies | Buy |
2020-09-22 | 개시 | Alliance Global Partners | Buy |
2020-05-29 | 개시 | SunTrust | Buy |
2018-12-20 | 개시 | H.C. Wainwright | Buy |
2018-07-27 | 업그레이드 | Stifel | Hold → Buy |
2018-07-13 | 개시 | SunTrust | Buy |
2016-04-18 | 재확인 | Wedbush | Neutral |
2015-03-23 | 다운그레이드 | ROTH Capital | Buy → Neutral |
2014-12-18 | 재확인 | ROTH Capital | Buy |
2014-10-16 | 재확인 | ROTH Capital | Buy |
2014-07-08 | 재개 | Brean Capital | Buy |
2013-10-22 | 재확인 | Stifel | Buy |
2013-04-15 | 개시 | Stifel | Buy |
모두보기
Mei Pharma Inc 주식(MEIP)의 최신 뉴스
Can MEI Pharma Inc. deliver alphaJuly 2025 Review & High Win Rate Trade Alerts - thegnnews.com
Chart overlay techniques for tracking MEI Pharma Inc.CPI Data & Accurate Technical Buy Alerts - Newser
How to read the order book for MEI Pharma Inc.July 2025 Breakouts & Long Hold Capital Preservation Plans - Newser
Institutional scanner results for MEI Pharma Inc.Market Risk Report & Reliable Trade Execution Plans - Newser
Measuring MEI Pharma Inc.’s beta against major indicesChart Signals & Comprehensive Market Scan Reports - Newser
Strategies to average down on MEI Pharma Inc.Quarterly Trade Summary & Weekly Consistent Profit Watchlists - Newser
Pattern recognition hints at MEI Pharma Inc. upsideJuly 2025 Market Mood & Stepwise Swing Trade Plans - Newser
Volume spikes in MEI Pharma Inc. stock – what they meanIndex Update & AI Enhanced Trading Alerts - Newser
How to manage a losing position in MEI Pharma Inc.Alpha Stock Picks with Chart Confirmation - Newser
Litecoin Surges 24% as MEI Pharma Boosts Treasury with $100M Investment - AInvest
Evaluating MEI Pharma Inc. with trendline analysisReal Time Stock Movement and Alerts - Newser
Is it too late to sell MEI Pharma Inc.AI Enhanced Strategy for Portfolio Growth - Newser
Combining machine learning predictions for MEI Pharma Inc.AI Screener for Daily Stock Forecast - Newser
Litecoin Hits Five-Month High on ETF Hype and MEI Pharma Treasury Deal - AInvest
Will MEI Pharma Inc. stock benefit from AI tech trendsDaily Market Movers Screener with Filters - Newser
What Fibonacci levels say about MEI Pharma Inc. reboundConservative Investment Setup and Risk Analysis - Newser
How to monitor MEI Pharma Inc. with trend dashboardsAI Volatility Forecast and Risk Monitor - Newser
What’s the analyst consensus on MEI Pharma Inc.Trade Picks with 3x Upside - sisain.net
Technical analysis overview for MEI Pharma Inc. stockTrade Ideas Based on Fundamental Metrics - Newser
How to escape a deep drawdown in MEI Pharma Inc.Fast Return Equity Forecast With Logic - Newser
How MEI Pharma Inc. stock performs during market volatilityWeekly Trend Watch with Market Signals - Newser
Can MEI Pharma Inc. stock recover from recent declineTechnical Setup Guide for Daily Watchlist - Newser
MEI Pharma Welcomes New Board Member Joshua Riezman - TipRanks
Bitcoin News Today: MEI Pharma Invests $100M in Litecoin as Treasury Diversification Strategy - AInvest
Ethereum News Today: MEI Pharma Allocates $100M to Litecoin in Bold Treasury Shift - AInvest
Can machine learning forecast MEI Pharma Inc. recoveryFree AI Driven Stock Trend Forecast - Newser
Litecoin's Institutional Leap: MEI Pharma Adopts LTC as a Reserve Asset Amid ETF Buzz - OKX
Litecoin Soars as MEI Pharma Launches $100M Institutional Treasury StrategyFinanceSecond - financesecond.com
MEI Pharma Kicks Off Its Litecoin-Focused Digital Asset Treasury with $110M Purchase - NFTgators
MEI Pharma’s Crypto Treasury Move: 930,000 Litecoin Tokens Acquired - Bitcoin.com News
Bitcoin News Today: MEI Pharma Allocates $100M to Litecoin as Core Treasury Asset - AInvest
MEI Pharma Chooses Not Bitcoin, Not Ethereum, But Litecoin As Treasury Asset - Benzinga
MEI Pharma Launches $110 Million Litecoin Treasury Strategy - CoinCentral
MEI Pharma's Litecoin treasury purchase sets off LTC rally - Mitrade
Ethereum News Today: MEI Pharma Allocates $100M to Litecoin as Primary Treasury Asset with GSR and Charlie Lee - AInvest
Litecoin Hits Five-Month High on ETF Optimism and $100M MEI Pharma Investment - AInvest
Litecoin Hits Five-Month High Amid ETF Optimism and $100M MEI Pharma Treasury - Yahoo Finance
Mei Pharma acquires Litecoin, launches $100m institutional treasury strategy - MarketScreener
MEI Pharma Acquires Litecoin as Primary Reserve Asset - TipRanks
MEI Pharma acquires $100 million in Litecoin for treasury strategy - Investing.com
MEI Pharma acquires $100 million in Litecoin for treasury strategy By Investing.com - Investing.com Nigeria
MEI Pharma Invests in Litecoin as Primary Treasury Asset - San Diego Business Journal
Mei Pharma Inc (MEIP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):